Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag has been updated from v3.5.4 to v3.5.5, signaling a minor update to the page. The study details and visible content remain unchanged.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor internal update. No substantive study content changes are indicated by this modification.SummaryDifference0.1%

- Check47 days agoChange DetectedUpdated the page’s displayed application/release version indicator from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check54 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.5.0 implemented, replacing v3.4.3. No study content changes are visible.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing v3.4.2. This appears to be a minor version update without changes to study content or user-facing features.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.